
<style>
    body {
         display: flex;
         justify-content: center;
         align-items: center;
         min-height: 100vh;
         margin: 0;
         font-family: sans-serif;
     }
     .container {
         display: flex;
         flex-direction: column;
         align-items: center;
         margin: 10pt 40pt 20pt 40pt;
         padding: 20px;
         border : none;
         max-width: 210mm; /* A4 width */
         box-sizing: border-box; /* Ensure padding and border are included in the width */
         font-size:14px;
     }
     .title {
         font-size: 20px;
         font-weight: bold;
         margin-bottom: 10px;
         text-align: center;
     }
     .table {
         max-width: 100%; /* Ensure the table does not exceed its container */
         width: 100%;
         border-collapse: collapse;
         table-layout: fixed; /* Ensure columns fit within the table */
         margin: auto; /* Center the table */
     }
     .table th,
     .table td {
         padding: 10px;
         border: 1px solid #000;
         text-align: left;
         word-wrap: break-word; /* Ensure text wraps within cells */
         overflow-wrap: break-word; /* Additional support for wrapping */
         vertical-align: top;

     }
     .table th {
         background-color: #f2f2f2;
         font-weight: bold;
     }
     /* Apply thicker border to the second column */
     .info-table th:nth-child(3),
     .info-table td:nth-child(3) {
    }
    .table th:nth-child(1),
     .table td:nth-child(1) {
     width: 6%; /* Adjust the percentage to your needs */
     font-weight: bold;
    }
    /* Apply thicker border to the second column */
     .table th:nth-child(2),
     .table td:nth-child(2) {
      width: 24%; /* Adjust the percentage to your needs */
      font-weight: bold;
    }
    .table th:nth-child(4),
    .table td:nth-child(4) {
        width: 15%;
    }
     .disclaimer {
         font-size: 12px;
         margin-top: 10px;
         text-align: center;
     }
</style>

<body>
<div class="container">
    <div>
        <h1 style="text-align: left;font-size: 14px;"><u>Annexure 2:</u> Definitions of Critical Illnesses and exclusions
            applicable for the Critical Illness benefit:</h1>
        <ol type="a">
            <li style="padding-left: 10px;">Subject to applicable exclusions and Waiting Period, the Critical
                Illness benefit would be paid only if the Diagnosed Critical Illness condition falls within the
                definition as laid down below for each Critical Illness.<br>
            </li>
        </ol>
    </div>
    <table class="table">
        <tbody>
        <tr>
            <td style="text-align: center;" ><strong>Sl no</strong></td>
            <td style="text-align: center;" ><strong>Name of the Illness</strong></td>
            <td style="text-align: center;"><strong> Details</strong> </td>
        </tr>
        <tr>
            <td colspan="3"><strong>MINOR CRITICAL ILLNESS</strong></td>
        </tr>
        <tr>
            <td>1.</td>
            <td>Angioplasty</td>
            <td>
                <div>Coronary Angioplasty is defined as percutaneous coronary intervention by way of balloon
                    angioplasty with or without stenting for treatment of the narrowing or blockage of minimum
                    50 % of one or more major coronary arteries. The intervention must be determined to be
                    medically necessary by a cardiologist and supported by a coronary angiogram (CAG).</div>
                <div>Coronary arteries herein refer to left main stem, left anterior descending, circumflex and
                    right coronary artery.</div>
                <div><i>Diagnostic angiography or investigation procedures without Angioplasty/stent insertion
                    are excluded.</i></div>
            </td>

        </tr>
        <tr>
            <td>2.</td>
            <td>Carcinoma in-situ / Early Stage Cancer</td>
            <td>
                <div><strong>a. Carcinoma in-situ (CiS)</strong> – Carcinoma-in-Situ shall mean first ever
                    histologically proven, localized pre-invasion lesion where cancer cells have not yet
                    penetrated the basement membrane or invaded (in the sense of infiltrating and / or actively
                    destroying) the surrounding tissues or stroma in any of the following covered organ groups,
                    and subject to any classification stated:</div>
                <ol type="i">
                    <li>Breast, where the tumor is classified as Tis according to the TNM Staging method</li>
                    <li>Corpus uteri, vagina, vulva or fallopian tubes where the tumor is classified as Tis
                        according to the TNM Staging method or FIGO (staging method of the Federation
                        Internationale de Gynecologie et d’Obstetrique) Stage 0</li>
                    <li>Cervix uteri, classified as cervical intraepithelial neoplasia grade III (CIN III) or as
                        Tis according to the TNM staging method or FIGO Stage 0</li>
                    <li>Ovary –include borderline ovarian tumors with intact capsule, no tumor on the ovarian
                        surface, classified as T1aN0M0, T1bN0M0 (TNM Staging) or FIGO 1A, FIGO 1B</li>
                    <li>Colon and rectum; penis; testis; lung; liver; stomach, nasopharynx and oesophagus</li>
                    <li>Urinary tract, for the purpose of in-situ cancers of the bladder, stage Ta of papillary
                        Carcinoma is included.</li>
                </ol>
                <div>The Diagnosis of the Carcinoma in situ must always be supported by a histopathological
                    report. Furthermore, the Diagnosis of Carcinoma in-situ must always be positively Diagnosed
                    upon the basis of a microscopic examination of the fixed tissue, supported by a biopsy
                    result. Clinical Diagnosis does not meet this standard.</div>
                <i>Pre-malignant lesion and Carcinoma in Situ of any organ, unless listed above, are
                    excluded.</i>
                <div><strong>b. Specified Early Stage Cancers</strong>  – Specified Early
                    Cancers shall mean first ever presence of one of the following malignant conditions:</div>
                <ol type="i">
                    <li>Prostate Cancer that is histologically described using the TNM Classification as T1N0M0
                        or Prostate cancers described using another equivalent classification.</li>
                    <li>Thyroid Cancer that is histologically described using the TNM Classification as T1N0M0.
                    </li>
                    <li>Tumors of the Urinary Bladder histologically classified as T1N0M0 (TNM Classification).
                    </li>
                    <li>Chronic Lymphocytic Leukaemia (CLL) RAI Stage 1 or 2. <i>CLL RAI Stage 0 or lower is
                        excluded.</i></li>
                    <li>Malignant melanoma that has not caused invasion beyond the epidermis.</li>
                    <li>Hodgkin’s lymphoma Stage I by the Cotswold’s classification staging system.</li>
                    <li>The Diagnosis must be based on histopathological features and confirmed by a
                        Pathologist.</li>
                </ol>
                <i>Pre - malignant lesions and conditions, unless listed above, are excluded.</i>
            </td>
        </tr>
        <tr>
            <td>3.</td>
            <td>Small Bowel Transplant</td>
            <td>The receipt of a transplant of small bowel with its own blood supply via a laparotomy resulting
                from intestinal failure.</td>
        </tr>
        <tr>
            <td><b>4.</b></td>
            <td><b>Brain Aneurysm Surgery or Cerebral Shunt Insertion</b></td>
            <td>
                <ol type="a">
                    <li>The actual undergoing of surgical repair of an intracranial aneurysm or surgical removal
                        of an arterio-venous malformation via craniotomy. The surgical intervention must be
                        certified to be absolutely necessary by a specialist in the relevant field. Endovascular
                        repair or procedures are not covered, or</li>
                    <li>The actual undergoing of surgical implantation of a shunt from the ventricles of the
                        brain to relieve raised pressure in the cerebrospinal fluid. The need of a shunt must be
                        certified to be absolutely necessary by a specialist in the relevant field.</li>
                </ol>
            </td>
        </tr>
        <tr>
            <td>5.</td>
            <td>Severe Osteoporosis</td>
            <td>The occurrence of osteoporosis with fractures must be confirmed by a specialist in the relevant
                medical field and all of the following conditions are met:
                <ol type="i">
                    <li>At least fracture of neck of femur or two (2) vertebral body fractures, due to or in the
                        presence of Osteoporosis; and </li>
                    <li>Bone mineral density measured in at least two (2) sites by dual-energy x-ray
                        densitometry (DEXA) or quantitative CT scanning is consistent with severe Osteoporosis
                        (T-score of less than -2.5)</li>
                </ol>
                <div>Actual undergoing of internal fixation or replacement of fractured bone is required.
                    Coverage for Osteoporosis with Fracture will automatically cease after the Life Insured
                    attains seventy (70) years of age.</div>
            </td>
        </tr>
        <tr>
            <td colspan="3">MAJOR CRITICAL ILLNESS</td>
        </tr>
        <tr>
            <td>6.</td>
            <td>Cancer of Specified Severity</td>
            <td>
                <div>A malignant tumor characterised by the uncontrolled growth & spread of malignant cells with
                    invasion & destruction of normal tissues. This Diagnosis must be supported by histological
                    evidence of malignancy. The term cancer includes leukemia, lymphoma and sarcoma.</div>
                <div style="padding-top: 10px;"><i>The following are excluded – </i></div>
                <ol type="a" style="font-style: italic;padding-top: 5px;">
                    <li>All tumors which are histologically described as carcinoma in situ, benign,
                        pre-malignant, borderline malignant, low malignant potential, neoplasm of unknown
                        behavior, or non-invasive, including but not limited to: Carcinoma in situ of breasts,
                        Cervical dysplasia CIN-1, CIN -2 and CIN-3.</li>
                    <li>Any non-melanoma skin carcinoma unless there is evidence of metastases to lymph nodes or
                        beyond;</li>
                    <li>Malignant melanoma that has not caused invasion beyond the epidermis;</li>
                    <li>All tumors of the prostate unless histologically classified as having a Gleason score
                        greater than 6 or having progressed to at least clinical TNM classification T2N0M0</li>
                    <li>All Thyroid cancers histologically classified as T1N0M0 (TNM Classification) or below;
                    </li>
                    <li>Chronic lymphocytic leukaemia less than RAI stage 3</li>
                    <li>Non-invasive papillary cancer of the bladder histologically described as TaN0M0 or of a
                        lesser classification,</li>
                    <li>All Gastro-Intestinal Stromal Tumors histologically classified as T1N0M0 (TNM
                        Classification) or below and with mitotic count of less than or equal to 5/50 HPFs;</li>
                </ol>
            </td>
        </tr>
        <tr>
            <td>7.</td>
            <td>Myocardial Infarction (First Heart Attack of Specific Severity)</td>
            <td>The first occurrence of heart attack or myocardial infarction, which means the death of a
                portion of the heart muscle as a result of inadequate blood supply to the relevant area. The
                Diagnosis for Myocardial Infarction should be evidenced by all of the following criteria:
                <ol type="i">
                    <li>A history of typical clinical symptoms consistent with the Diagnosis of acute myocardial
                        infarction (for e.g. typical chest pain)</li>
                    <li>New characteristic electrocardiogram changes </li>
                    <li>Elevation of infarction specific enzymes, Troponins or other specific biochemical
                        markers.</li>
                </ol>
                <div style="padding-top: 10px;"><i>The following are excluded:
                <ol type="i">
                    <li>Other acute Coronary Syndromes</li>
                    <li>Any type of angina pectoris </li>
                    <li>A rise in cardiac biomarkers or Troponin T or I in absence of overt ischemic heart
                        disease OR following an intra-arterial cardiac procedure</li>
                </ol>
                </i>
                </div>
            </td>
        </tr>
        <tr>
            <td>8.</td>
            <td>Open Chest CABG</td>
            <td>
                <div>The actual undergoing of heart surgery to correct blockage or narrowing in one or more
                    coronary artery(s), by coronary artery bypass grafting done via a sternotomy (cutting
                    through the breast bone) or minimally invasive keyhole coronary artery bypass procedures.
                    The Diagnosis must be supported by a coronary angiography and the realization of surgery has
                    to be confirmed by a cardiologist</div>
                <i>The following are excluded: </i>
                <div><i>Angioplasty and/or any other intra-arterial procedures</i></div>

            </td>
        </tr>
        <tr>
            <td>9.</td>
            <td>Open Heart Replacement or Repair of Heart Valves</td>
            <td>The actual undergoing of open-heart valve surgery to replace or repair one or more heart valves,
                as a consequence of defects in, abnormalities of, or disease-affected cardiac valve(s). The
                Diagnosis of the valve abnormality must be supported by an echocardiography and the realization
                of surgery has to be confirmed by a specialist Medical Practitioner. <i>Catheter based
                    techniques including but not limited to, balloon valvotomy/valvuloplasty are excluded.</i>
            </td>
        </tr>
        <tr>
            <td>10.</td>
            <td>Coma of specified Severity </td>
            <td>A state of unconsciousness with no reaction or response to external stimuli or internal needs.
                This Diagnosis must be supported by evidence of all of the following:
                <ol type="i">
                    <li>No response to external stimuli continuously for at least 96 hours;</li>
                    <li>Life support measures are necessary to sustain life; and</li>
                    <li>Permanent neurological deficit which must be assessed at least 30 days after the onset
                        of the coma.</li>
                </ol>
                <div>The condition has to be confirmed by a specialist Medical Practitioner. <i>Coma resulting
                    from alcohol or drug abuse is excluded.</i></div>
            </td>
        </tr>
        <tr>
            <td>11.</td>
            <td>Kidney Failure Requiring Regular Dialysis </td>
            <td>End stage renal disease presenting as chronic irreversible failure of both kidneys to function,
                as a result of which either regular renal dialysis (haemodialysis or peritoneal dialysis) is
                instituted or renal transplantation is carried out. Diagnosis has to be confirmed by a
                specialist Medical Practitioner.</td>
        </tr>
        <tr>
            <td>12.</td>
            <td>Stroke resulting in permanent symptoms </td>
            <td>Any cerebrovascular incident producing permanent neurological sequelae. This includes infarction
                of brain tissue, thrombosis in an intracranial vessel, haemorrhage and embolisation from an
                extracranial source. Diagnosis has to be confirmed by a specialist Medical Practitioner and
                evidenced by typical clinical symptoms as well as typical findings in CT Scan or MRI of the
                brain. Evidence of permanent neurological deficit lasting for at least 3 months has to be
                produced.<br>
                <i>The following are excluded:</i>
                <ol type="a">
                    <li><i>Transient ischemic attacks (TIA)</i></li>
                    <li><i>Traumatic injury of the brain</i></li>
                    <li><i>Vascular disease affecting only the eye or optic nerve or vestibular functions.</i></li>
                </ol>
            </td>
        </tr>
        <tr>
            <td>13.</td>
            <td>Major Organ /Bone Marrow Transplant</td>
            <td>
                <div>The actual undergoing of a transplant of:</div>
                <ol type="i">
                    <li>One of the following human organs: heart, lung, liver, kidney, pancreas, that resulted
                        from irreversible end-stage failure of the relevant organ, or </li>
                    <li>Human bone marrow using haematopoietic stem cells. The undergoing of a transplant has
                        to be confirmed by a specialist Medical Practitioner.</li>
                </ol>
                <i>The following are excluded: </i>
                <ol type="i">
                    <li><i>Other stem-cell transplants</i></li>
                    <li><i>Where only Islets of Langerhans are transplanted</i></li>
                </ol>
            </td>
        </tr>
        <tr>
            <td>14.</td>
            <td>Permanent Paralysis of Limbs </td>
            <td>Total and irreversible loss of use of two or more limbs as a result of injury or disease of the
                brain or spinal cord. A specialist Medical Practitioner must be of the opinion that the
                paralysis will be permanent with no hope of recovery and must be present for more than 3 months.
            </td>
        </tr>
        <tr>
            <td>15.</td>
            <td>Motor Neuron Disease with Permanent Symptoms </td>
            <td>Motor neuron disease Diagnosed by a specialist Medical Practitioner as spinal muscular atrophy,
                progressive bulbar palsy, amyotrophic lateral sclerosis or primary lateral sclerosis. There must
                be progressive degeneration of corticospinal tracts and anterior horn cells or bulbar efferent
                neurons. There must be current significant and permanent functional neurological impairment with
                objective evidence of motor dysfunction that has persisted for a continuous period of at least 3
                months.</td>
        </tr>
        <tr>
            <td>16.</td>
            <td>Multiple Sclerosis with Persisting Symptoms</td>
            <td>The unequivocal Diagnosis of definite multiple sclerosis confirmed and evidenced by all of the
                following:
                <ol type="i">
                    <li>investigations including typical MRI findings which unequivocally confirm the Diagnosis
                        to be multiple sclerosis and</li>
                    <li>there must be current clinical impairment of motor or sensory function, which must have
                        persisted for a continuous period of at least 6 months.</li>
                </ol>
                <i>Neurological damage due to SLE is excluded.</i>
            </td>
        </tr>
        <tr>
            <td>17.</td>
            <td>Benign Brain Tumor</td>
            <td>
                Benign brain tumor is defined as a life threatening, non-cancerous tumor in the brain, cranial
                nerves or meninges within the skull. The presence of the underlying tumor must be confirmed by
                imaging studies such as CT scan or MRI.
                <div>This brain tumor must result in at least one of the following and must be confirmed by the
                    relevant medical specialist:</div>
                <ol type="i">
                    <li>Permanent Neurological deficit with persisting clinical symptoms for a continuous period
                        of at least 90 consecutive days or</li>
                    <li>Undergone surgical resection or radiation therapy to treat the brain tumor.</li>
                </ol>
                <i>The following conditions are excluded:</i>
                <ol type="a">
                    <li><i>Cysts, Granulomas, malformations in the arteries or veins of the brain, hematomas,
                        abscesses, pituitary tumors, tumors of skull bones and tumors of the spinal cord.</i></li>
                </ol>
            </td>
        </tr>
        <tr>
            <td>18.</td>
            <td>Blindness </td>
            <td>
                Total, permanent and irreversible loss of all vision in both eyes as a result of illness or
                accident.
                <div>The Blindness is evidenced by:</div>
                <ol type="a">
                    <li>corrected visual acuity being 3/60 or less in both eyes or;</li>
                    <li>the field of vision being less than 10 degrees in both eyes.</li>
                </ol>
                The Diagnosis of blindness must be confirmed and must not be correctable by aids or surgical
                procedure
            </td>
        </tr>
        <tr>
            <td>19.</td>
            <td>Deafness </td>
            <td>Total and irreversible loss of hearing in both ears as a result of illness or accident. This
                Diagnosis must be supported by pure tone audiogram test and certified by an Ear, Nose and Throat
                (ENT) specialist. Total means “the loss of hearing to the extent that the loss is greater than
                90decibels across all frequencies of hearing” in both ears.</td>
        </tr>
        <tr>
            <td>20.</td>
            <td>End Stage Lung Failure </td>
            <td>End stage lung disease, causing chronic respiratory failure, as confirmed and evidenced by all
                of the following:
                <ol type="i">
                    <li>FEV1 test results consistently less than 1 litre measured on 3 occasions 3 months apart;
                        and</li>
                    <li>Requiring continuous permanent supplementary oxygen therapy for hypoxemia; and</li>
                    <li>Arterial blood gas analysis with partial oxygen pressures of 55mmHg or less (PaO2 < 55
                        mmHg); and</li>
                    <li>Dyspnea at rest.</li>
                </ol>
            </td>
        </tr>
        <tr>
            <td>21.</td>
            <td>End Stage Liver Failure</td>
            <td>
                Permanent and irreversible failure of liver function that has resulted in all three of the
                following:
                <ol type="i">
                    <li>permanent jaundice; and </li>
                    <li>ascites; and</li>
                    <li>hepatic encephalopathy.</li>
                </ol>
                <i>Liver failure secondary to drug or alcohol abuse is excluded.</i>
            </td>
        </tr>
        <tr>
            <td>22.</td>
            <td>Loss of speech</td>
            <td>Total and irrecoverable loss of the ability to speak as a result of injury or disease to the
                vocal cords. The inability to speak must be established for a continuous period of 12 months.
                This Diagnosis must be supported by medical evidence furnished by an Ear, Nose, Throat (ENT)
                specialist. </td>
        </tr>
        <tr>
            <td>23.</td>
            <td>Loss of Limbs</td>
            <td>The physical separation of two or more limbs, at or above the wrist or ankle level limbs as a
                result of injury or disease. This will include medically necessary amputation necessitated by
                injury or disease. The separation has to be permanent without any chance of surgical correction.
                <i>Loss of Limbs resulting directly or indirectly from self-inflicted injury, alcohol or drug
                    abuse is excluded.</i></td>
        </tr>
        <tr>
            <td>24.</td>
            <td>Major Head Trauma</td>
            <td>
                <div>Accidental Injury of Head, resulting in permanent Neurological deficit to be assessed no
                    sooner than 3 months from the date of the accident. This Diagnosis must be supported by
                    unequivocal findings on Magnetic Resonance Imaging, Computerized Tomography, or other
                    reliable imaging techniques. The accident must be caused solely and directly by accidental,
                    violent, external and visible means and independently of all other causes.</div>
                <div>The Accidental Injury of head must result in an inability to perform at least three (3) of
                    the Activities of Daily Living either with or without the use of mechanical equipment,
                    special devices or other aids and adaptations in use for disabled persons. For the purpose
                    of this benefit, the word “permanent” shall mean beyond the scope of recovery with current
                    medical knowledge and technology.</div>
                <i>Spinal cord injury is excluded</i>
            </td>
        </tr>
        <tr>
            <td>25.</td>
            <td>Primary (Idiopathic) Pulmonary Hypertension</td>
            <td>
                <div>An unequivocal diagnosis of Primary (Idiopathic) Pulmonary Hypertension by a Cardiologist
                    or specialist in respiratory medicine with evidence of right ventricular enlargement and the
                    pulmonary artery pressure above 30 mm of Hg on Cardiac Cauterization. There must be
                    permanent irreversible physical impairment to the degree of at least Class IV of the New
                    York Heart Association Classification (NYHA) of cardiac impairment.</div>
                The NYHA Classification of Cardiac Impairment are as follows:
                <ol type="i">
                    <li>Class III: Marked limitation of physical activity. Comfortable at rest, but less than
                        ordinary activity causes symptoms.</li>
                    <li>Class IV: Unable to engage in any physical activity without discomfort. Symptoms may be
                        present even at rest.</li>
                </ol>
                <i>Pulmonary hypertension associated with lung disease, chronic hypoventilation, pulmonary
                    thromboembolic disease, drugs and toxins, diseases of the left side of the heart, congenital
                    heart disease and any secondary cause are specifically excluded.</i>
            </td>
        </tr>
        <tr>
            <td>26.</td>
            <td>Third Degree Burns</td>
            <td>There must be third-degree burns with scarring that cover at least 20% of the body’s surface
                area. The Diagnosis must confirm the total area involved using standardized, clinically
                accepted, body surface area charts covering 20% of the body surface area</td>
        </tr>
        <tr>
            <td>27.</td>
            <td>Alzheimer’s Disease</td>
            <td>
                <div>Alzheimer’s (presenile dementia) disease is a progressive degenerative disease of the
                    brain, characterised by diffuse atrophy throughout the cerebral cortex with distinctive
                    histopathological changes. It affects the brain, causing symptoms like memory loss,
                    confusion, communication problems, and general impairment of mental function, which
                    gradually worsens leading to changes in personality.</div>
                <div>Deterioration or loss of intellectual capacity, as confirmed by clinical evaluation and
                    imaging tests, arising from Alzheimer’s disease, resulting in progressive significant
                    reduction in mental and social functioning, requiring the continuous supervision of the Life
                    Insured. The Diagnosis must be supported by the clinical confirmation of a Neurologist and
                    supported by our appointed Medical Practitioner.</div>
                <div>The disease must result in a permanent inability to perform three or more of the Activities
                    of Daily Living with Loss of Independent Living or must require the need of supervision and
                    permanent presence of care staff due to the disease. This must be medically documented for a
                    period of at least 90 days </div>
                <i>The following conditions are however not covered:</i>
                <ul style="list-style-type: circle;font-style: italic;">
                    <li>non-organic diseases such as neurosis;</li>
                    <li>alcohol related brain damage; and</li>
                    <li>any other type of irreversible organic disorder/dementia</li>
                </ul>
            </td>
        </tr>
        <tr>
            <td>28.</td>
            <td>Parkinson’s disease </td>
            <td>
                <div>The unequivocal Diagnosis of progressive, degenerative idiopathic Parkinson’s disease by a
                    Neurologist acceptable to us.</div>
                The Diagnosis must be supported by all of the following conditions:
                <ul>
                    <li>the disease cannot be controlled with medication;</li>
                    <li>signs of progressive impairment; and</li>
                    <li>inability of the Life Insured to perform at least 3 of the Activities of Daily Living
                        (either with or without the use of mechanical equipment, special devices or other aids
                        and adaptations in use for disabled persons) for a continuous period of at least 6
                        months:</li>
                </ul>
                <i>Parkinson’s disease secondary to drug and/or alcohol abuse is excluded.</i>
            </td>
        </tr>
        <tr>
            <td>29.</td>
            <td>Aorta Graft Surgery </td>
            <td>
                <div>The actual undergoing of major Surgery to repair or correct aneurysm, narrowing,
                    obstruction or dissection of the Aorta through surgical opening of the chest or abdomen. For
                    the purpose of this cover the definition of <strong>“Aorta”</strong> shall mean the thoracic
                    and abdominal aorta but not its branches.</div>
                <i>You understand and agree that we will not cover:</i>
                <ul style="font-style: italic;">
                    <li>Surgery performed using only minimally invasive or intra-arterial techniques.</li>
                    <li>Angioplasty and all other intra-arterial, catheter based techniques, "keyhole" or laser
                        procedures.</li>
                </ul>
                Aorta graft surgery benefit covers Surgery to the aorta wherein part of it is removed and
                replaced with a graft.
            </td>
        </tr>
        <tr>
            <td>30.</td>
            <td>Amputation of feet due to complications from Diabetes</td>
            <td>Diabetic neuropathy and vasculitis resulting in the amputation of both feet at or above ankle as
                advised by a Medical Practitioner who is a specialist as the only means to maintain life.
                <div style="font-style: italic;">Amputation of toe or toes, or any other causes for amputation
                    shall not be covered.</div>
            </td>
        </tr>
        <tr>
            <td>31.</td>
            <td>Apallic Syndrome or Persistent Vegetative State (PVS)</td>
            <td>Apallic Syndrome or Persistent vegetative state (PVS) or unresponsive wakefulness syndrome (UWS)
                is a Universal necrosis of the brain cortex with the brainstem remaining intact. The Diagnosis
                must be confirmed by a Neurologist acceptable to Us and the patient should be documented to be
                in a vegetative state for a minimum of at least one month in order to be classified as UWS, PVS,
                Apallic Syndrome.</td>
        </tr>
        <tr>
            <td>32.</td>
            <td>Aplastic Anaemia </td>
            <td>
                Chronic persistent bone marrow failure which results in anaemia, neutropenia and
                thrombocytopenia requiring treatment with at least one of the following:
                <ol type="a">
                    <li>Blood product transfusion.</li>
                    <li>Marrow stimulating agents.</li>
                    <li>Immunosuppressive agents; or</li>
                    <li>Bone marrow transplantation.</li>
                </ol>
                The Diagnosis must be confirmed by a haematologist using relevant laboratory investigations
                including Bone Marrow Biopsy resulting in bone marrow cellularity of less than 25% which is
                evidenced by any two of the following:
                <ol type="a">
                    <li>Absolute neutrophil count of less than 500/mm³ or less</li>
                    <li>Platelets count less than 20,000/mm³ or less</li>
                    <li>Reticulocyte count of less than 20,000/mm³ or less</li>
                </ol>
                <i>Temporary or reversible Aplastic Anaemia is excluded.</i>
            </td>
        </tr>
        <tr>
            <td>33.</td>
            <td>Bacterial Meningitis </td>
            <td>Bacterial infection resulting in severe inflammation of the membranes of the brain or spinal
                cord resulting in significant, irreversible and permanent neurological deficit. The neurological
                deficit must persist for at least 6 weeks resulting in permanent inability to perform three or
                more of the Activities of Daily Living. This Diagnosis must be confirmed by:
                <ol type="a">
                    <li>The presence of bacterial infection in cerebrospinal fluid by lumbar puncture; and</li>
                    <li>A consultant neurologist.</li>
                </ol>
            </td>
        </tr>
        <tr>
            <td>34.</td>
            <td>Brain Surgery</td>
            <td>The actual undergoing of surgery to the brain under general anaesthesia during which a
                craniotomy is performed. Keyhole surgery is included <i>however, minimally invasive treatment
                    where no surgical incision is performed to expose the target, such as irradiation by gamma
                    knife or endovascular neuroradiological interventions such as embolizations, thrombolysis
                    and stereotactic biopsy are all excluded. Brain surgery as a result of an Accident is also
                    excluded.</i> The procedure must be considered medically necessary by a Medical Practitioner
                who is a qualified specialist.</td>
        </tr>
        <tr>
            <td>35.</td>
            <td>Cardiomyopathy </td>
            <td>An impaired function of the heart muscle, unequivocally Diagnosed as Cardiomyopathy by a Medical
                Practitioner who is a cardiologist, and which results in permanent physical impairment to the
                degree of New York Heart Association (NYHA) Classification Class IV, or its equivalent, for at
                least six (6) months based on the following classification criteria:
                <ul>
                    <li>NYHA Class IV – inability to carry out an activity without discomfort. Symptoms of
                        congestive cardiac failure are present even at rest. With any increase in physical
                        activity, discomfort will be experienced.</li>
                </ul>
                <div>The Diagnosis of Cardiomyopathy has to be supported by echocardiographic findings of
                    compromised ventricular performance.</div>
                <div><i>Irrespective of the above, Cardiomyopathy directly related to alcohol or drug abuse is
                    excluded.</i></div>
            </td>
        </tr>
        <tr>
            <td>36.</td>
            <td>Chronic Adrenal Insufficiency (Addison’s Disease)</td>
            <td>
                <div>An autoimmune disorder causing a gradual destruction of the adrenal gland resulting in the
                    need for lifelong glucocorticoid and mineral corticoid replacement therapy. The disorder
                    must be confirmed by a Medical Practitioner who is a specialist in endocrinology through one
                    of the following:</div>
                <ul>
                    <li>ACTH simulation tests</li>
                    <li>Insulin-induced hypoglycemia test</li>
                    <li>Plasma ACTH level measurement</li>
                    <li>Plasma Renin Activity (PRA) level measurement.</li>
                </ul>
                <i>Only autoimmune cause of primary adrenal insufficiency is included. All other causes of
                    adrenal insufficiency are excluded.</i>
            </td>
        </tr>
        <tr>
            <td>37.</td>
            <td>Chronic Relapsing Pancreatitis</td>
            <td>
                <div>An unequivocal Diagnosis of chronic relapsing pancreatitis made by a Medical Practitioner
                    who is a specialist in gastroenterology and confirmed as a continuing inflammatory disease
                    of the pancreas characterised by irreversible morphological change and typically causing
                    pain and/or permanent impairment of function. The condition must be confirmed by pancreatic
                    function tests and radiographic and imaging evidence.</div>
                <i>Relapsing Pancreatitis caused directly or indirectly, wholly or partly, by alcohol is
                    excluded.</i>
            </td>
        </tr>
        <tr>
            <td>38.</td>
            <td>Creutzfeldt-Jacob Disease (CJD)</td>
            <td>Creutzfeldt-Jacob disease is an incurable brain infection that causes rapidly progressive
                deterioration of mental function and movement. A Medical Practitioner, who is a neurologist,
                must make a definite Diagnosis of Creutzfeldt-Jacob disease based on clinical assessment, EEG
                and imaging. There must be objective neurological abnormalities on examination along with severe
                progressive dementia.</td>
        </tr>
        <tr>
            <td>39.</td>
            <td>Severe Crohn’s Disease</td>
            <td>
                Crohn’s Disease is a chronic, transmural inflammatory disorder of the bowel. To be considered as
                severe, there must be evidence of continued inflammation in spite of optimal therapy, with all
                of the following having occurred:
                <ul>
                    <li>Stricture formation causing intestinal obstruction requiring admission to hospital, and
                    </li>
                    <li>Fistula formation between loops of bowel, and</li>
                    <li>At least one bowel segment resection.</li>
                </ul>
                The Diagnosis must be made by a Medical Practitioner who is a specialist Gastroenterologist and
                be proven histologically on a pathology report and/or the results of sigmoidoscopy or
                colonoscopy.
            </td>
        </tr>
        <tr>
            <td>40.</td>
            <td>Dissecting Aortic Aneurysm</td>
            <td>A condition where the inner lining of the aorta (intima layer) is interrupted so that blood
                enters the wall of the aorta and separates its layers. For the purpose of this definition, aorta
                shall mean the thoracic and abdominal aorta but not its branches. The Diagnosis must be made by
                a Medical Practitioner who is a specialist with computed tomography (CT) scan, magnetic
                resonance imaging (MRI), magnetic resonance angiograph (MRA) or angiogram. Emergency surgical
                repair is required.</td>
        </tr>
        <tr>
            <td>41.</td>
            <td>Eisenmenger’s Syndrome </td>
            <td>
                Development of severe pulmonary hypertension and shunt reversal resulting from heart condition.
                The Diagnosis must be made by a Medical Practitioner who is a specialist with echocardiography
                and cardiac catheterisation and supported by the following criteria:
                <ul>
                    <li>Mean pulmonary artery pressure > 40 mm Hg</li>
                    <li>Pulmonary vascular resistance > 3mm/L/min (Wood units); and Normal pulmonary wedge pressure < 15 mm Hg.</li>
                </ul>
            </td>
        </tr>
        <tr>
            <td>42.</td>
            <td>Elephantiasis</td>
            <td>Massive swelling in the tissues of the body as a result of destroyed regional lymphatic
                circulation by chronic filariasis infection. The unequivocal Diagnosis of elephantiasis must be
                confirmed by a Medical Practitioner who is a specialist physician. There must be clinical
                evidence of permanent massive swelling of legs, arms, scrotum, vulva, or breasts. There must
                also be laboratory confirmation of microfilariae infection.
                <div style="font-style: italic;">Swelling or lymphedema caused by infection with a sexually
                    transmitted disease, trauma, post-operative scarring, congestive heart failure, or
                    congenital lymphatic system abnormalities is excluded.</div>
            </td>
        </tr>
        <tr>
            <td>43.</td>
            <td>Encephalitis</td>
            <td>Severe inflammation of brain substance (cerebral hemisphere, brainstem or cerebellum) caused by
                viral infection and resulting in permanent neurological deficit. This Diagnosis must be
                certified by a Medical Practitioner who is a consultant neurologist and the permanent
                neurological deficit must be documented for at least 6 weeks. The permanent deficit should
                result in permanent inability to perform three or more of the Activities of Daily Living. </td>
        </tr>
        <tr>
            <td>44.</td>
            <td>Fulminant Viral Hepatitis</td>
            <td>
                A sub-massive to massive necrosis of the liver by the Hepatitis virus, leading precipitously to
                liver failure. This Diagnosis must be supported by all of the following:
                <ol type="i">
                    <li>Rapid decreasing of liver size</li>
                    <li>Necrosis involving entire lobules, leaving only a collapsed reticular framework</li>
                    <li>Rapid deterioration of liver function tests</li>
                    <li>Deepening jaundice; and</li>
                    <li>Hepatic encephalopathy.</li>
                </ol>
                Acute Hepatitis infection or carrier status alone does not meet the diagnostic criteria.
            </td>
        </tr>
        <tr>
            <td>45.</td>
            <td>Hemiplegia</td>
            <td>
                The total and permanent loss of the use of one side of the body through paralysis persisting for
                a period of at least 6 weeks and with no foreseeable possibility of recovery caused by illness
                or injury. <i>Self-inflicted injuries are excluded.</i>
            </td>
        </tr>
        <tr>
            <td>46.</td>
            <td>HIV due to Blood transfusion and occupationally acquired HIV</td>
            <td>
                <ol type="A">
                    <li>Infection with the Human Immunodeficiency Virus (HIV) through a blood transfusion,
                        provided that all of the following conditions are met:
                        <ul style="list-style-type: disc;">
                            <li>The blood transfusion was medically necessary or given as part of a medical
                                treatment</li>
                            <li>The blood transfusion was received in India after the Policy Date, Date of
                                endorsement or Date of reinstatement, whichever is the later</li>
                            <li>The source of the infection is established to be from the Institution that
                                provided the blood transfusion and the Institution is able to trace the origin
                                of the HIV tainted blood; and</li>
                            <li>The Life Insured does not suffer from Thalassaemia Major or Haemophilia.</li>
                        </ul>
                    </li>
                    <li>Infection with the Human Immunodeficiency Virus (HIV) which resulted from an Accident
                        occurring after the Policy Date, date of endorsement or date of reinstatement, whichever
                        is the later whilst the Life Insured was carrying out the normal professional duties of
                        his or her occupation in India, provided that all of the following are proven to Our
                        satisfaction:
                        <ul style="list-style-type: disc;">
                            <li>Proof that the Accident involved a definite source of the HIV infected fluids;
                            </li>
                            <li>Proof of sero-conversion from HIV negative to HIV positive occurring during the
                                180 days after the documented Accident. This proof must include a negative HIV
                                antibody test conducted within 5 days of the Accident; and</li>
                        </ul>
                    </li>
                </ol>
                This benefit is only payable when the occupation of the Life Insured is a Medical Practitioner,
                housemen, medical student, registered nurse, medical laboratory technician, dentist (surgeon and
                nurse) or paramedical worker, working in medical centre or clinic in India. <i>This benefit will
                not apply under either section A or B where a cure has become available prior to the
                infection. “Cure” means any treatment that renders the HIV inactive or non-infectious.</i>
            </td>
        </tr>
        <tr>
            <td>47.</td>
            <td>Infective Endocarditis</td>
            <td>
                Inflammation of the inner lining of the heart caused by infectious organisms, where all of the
                following criteria are met:
                <ul>
                    <li>Positive result of the blood culture proving presence of the infectious organism(s);
                    </li>
                    <li>Presence of at least moderate heart valve incompetence (meaning regurgitant fraction of
                        20% or above) or moderate heart valve stenosis (resulting in heart valve area of 30% or
                        less of normal value) attributable to Infective Endocarditis; and</li>
                    <li>The Diagnosis of Infective Endocarditis and the severity of valvular impairment are
                        confirmed by a Medical Practitioner who is a cardiologist.</li>
                </ul>
            </td>
        </tr>
        <tr>
            <td>48.</td>
            <td>Loss of Independent Existence (cover up to age 74)</td>
            <td>
                <div>The Life Insured is physically incapable of performing at least three (3) of the Activities
                    of Daily Living (either with or without the use of mechanical equipment, special devices or
                    other aids or adaptations in use for disabled persons) for a continuous period of at least
                    six (6) months and signifying a permanent and irreversible inability to perform the same.
                    For the purpose of this definition, the word “permanent” shall mean beyond the hope of
                    recovery with current medical knowledge and technology. The Diagnosis of Loss of Independent
                    Existence must be confirmed by a specialist Medical Practitioner.</div>
                Only Life Insured with Age between 18 and 74 on first Diagnosis is eligible to receive a benefit
                under this illness.
            </td>
        </tr>
        <tr>
            <td>49.</td>
            <td>Loss of One Limb and One Eye</td>
            <td>
                <div>Total, permanent and irrecoverable loss of sight of one eye and loss by severance of one
                    limb at or above the elbow or knee.</div>
                The loss of sight of one eye must be clinically confirmed by a Medical Practitioner who is an
                eye specialist and must not be correctable by aides or surgical procedures.
            </td>
        </tr>
        <tr>
            <td>50.</td>
            <td>Medullary Cystic Disease</td>
            <td>
                Medullary Cystic Disease where the following criteria are met:
                <ul>
                    <li>the presence in the kidney of multiple cysts in the renal medulla accompanied by the
                        presence of tubular atrophy and interstitial fibrosis</li>
                    <li>clinical manifestations of anaemia, polyuria, and progressive deterioration in kidney
                        function; and</li>
                    <li>the Diagnosis of Medullary Cystic Disease is confirmed by renal biopsy.</li>
                </ul>
                <i>Isolated or benign kidney cysts are specifically excluded from this benefit.</i>
            </td>
        </tr>
        <tr>
            <td>51.</td>
            <td>Muscular Dystrophy</td>
            <td>A group of hereditary degenerative diseases of muscle characterised by weakness and atrophy of
                muscle. The Diagnosis of muscular dystrophy must be unequivocal and made by a Medical
                Practitioner who is a consultant neurologist. The condition must result in the inability of the
                Life Insured to perform (whether aided or unaided) at least 3 of the Activities of Daily Living
                for a continuous period of at least 6 months.</td>
        </tr>
        <tr>
            <td>52.</td>
            <td>Myasthenia Gravis</td>
            <td>
                An acquired autoimmune disorder of neuromuscular transmission leading to fluctuating muscle
                weakness and fatigability, where all of the following criteria are met:
                <ul>
                    <li>Presence of permanent muscle weakness categorized as Class IV or V according to the
                        Myasthenia Gravis Foundation of America Clinical Classification (given below); and</li>
                    <li>The Diagnosis of Myasthenia Gravis and categorization are confirmed by a Medical
                        Practitioner who is a neurologist.</li>
                </ul>
                Myasthenia Gravis Foundation of America Clinical Classification:
                <div>Class I: Any eye muscle weakness, possible ptosis, no other evidence of muscle weakness
                    elsewhere.</div>
                <div>Class II: Eye muscle weakness of any severity, mild weakness of other muscles.</div>
                <div>Class III: Eye muscle weakness of any severity, moderate weakness of other muscles.</div>
                <div>Class IV: Eye muscle weakness of any severity, severe weakness of other muscles.</div>
                <div>Class V: Intubation needed to maintain airway.</div>
            </td>
        </tr>
        <tr>
            <td>53.</td>
            <td>Myelofibrosis</td>
            <td>
                A disorder which can cause fibrous tissue to replace the normal bone marrow and results in
                anaemia, low levels of white blood cells and platelets and enlargement of the spleen. The
                condition must have progressed to the point that it is permanent, and the severity is such that
                the Life Insured requires a blood transfusion at least monthly. The Diagnosis of myelofibrosis
                must be supported by bone marrow biopsy and confirmed by a Medical Practitioner who is a
                specialist.
            </td>
        </tr>
        <tr>
            <td>54.</td>
            <td>Necrotising Fasciitis</td>
            <td>
                Necrotizing fasciitis is a progressive, rapidly spreading, infection located in the deep fascia
                causing necrosis of the subcutaneous tissues. An unequivocal Diagnosis of necrotizing fasciitis
                must be made by a Medical Practitioner who is a specialist and the Diagnosis must be supported
                with laboratory evidence of the presence of bacteria that is a known cause of necrotising
                fasciitis. There must also be widespread destruction of muscle and other soft tissues that
                results in a total and permanent loss or function of the affected body part.
            </td>
        </tr>
        <tr>
            <td>55.</td>
            <td>Other Serious Coronary Artery Disease</td>
            <td>
                <div>The narrowing of the lumen of at least one coronary artery by a minimum of 75% and of two
                    others by a minimum of 60%, as proven by coronary angiography, regardless of whether or not
                    any form of coronary artery intervention or surgery has been performed.</div>
                <div>Coronary arteries herein refer to left main stem, left anterior descending, circumflex and
                    right coronary artery (but not including their branches).</div>
            </td>
        </tr>
        <tr>
            <td>56.</td>
            <td>Pheochromocytoma</td>
            <td>Presence of a neuroendocrine tumour of the adrenal or extra-chromaffin tissue that secretes
                excess catecholamines requiring the actual undergoing of surgery to remove the tumour.
                <div>The Diagnosis of Pheochromocytoma must be confirmed by a Medical Practitioner who is an
                    endocrinologist.</div>
            </td>
        </tr>
        <tr>
            <td>57.</td>
            <td>Poliomyelitis</td>
            <td>The occurrence of Poliomyelitis where the following conditions are met:
                <ol type="i">
                    <li>Poliovirus is identified as the cause,</li>
                    <li>Paralysis of the limb muscles or respiratory muscles must be present and persist for at
                        least 3 months.</li>
                </ol>
            </td>
        </tr>
        <tr>
            <td>58.</td>
            <td>Progressive Scleroderma</td>
            <td>
                <div>
                    A systemic collagen-vascular disease causing progressive diffuse fibrosis in the skin, blood
                    vessels and visceral organs. This Diagnosis must be unequivocally supported by biopsy and
                    serological evidence and the disorder must have reached systemic proportions to involve the
                    heart, lungs or kidneys.</div>
                <i>The following are excluded:</i>
                <ol type="i">
                    <li><i>Localised scleroderma (linear scleroderma or morphea);</i></li>
                    <li><i>Eosinophilic fasciitis; and</i></li>
                    <li><i>CREST syndrome.</i></li>
                </ol>
            </td>
        </tr>
        <tr>
            <td>59.</td>
            <td>Progressive Supranuclear Palsy</td>
            <td>
                Confirmed by a Medical Practitioner who is a specialist in neurology of a definite Diagnosis of
                progressive supranuclear palsy. There must be permanent clinical impairment of motor function,
                eye movement disorder and postural instability.
            </td>
        </tr>
        <tr>
            <td>60.</td>
            <td>Severe Rheumatoid Arthritis</td>
            <td>
                Unequivocal Diagnosis of systemic immune disorder of rheumatoid arthritis where all of the
                following criteria are met:
                <ul>
                    <li>Diagnostic criteria of the American College of Rheumatology for Rheumatoid Arthritis;
                    </li>
                    <li>Permanent inability to perform at least two (2) of the Activities of Daily Living;</li>
                    <li>Widespread joint destruction and major clinical deformity of three (3) or more of the
                        following joint areas: hands, wrists, elbows, knees, hips, ankle, cervical spine or
                        feet; and</li>
                    <li>The foregoing conditions have been present for at least six (6) months.</li>
                </ul>
            </td>
        </tr>
        <tr>
            <td>61.</td>
            <td>Severe Ulcerative Colitis</td>
            <td>
                Acute fulminant ulcerative colitis with life threatening electrolyte disturbances.<br>
                All of the following criteria must be met:
                <ul>
                    <li>the entire colon is affected, with severe bloody diarrhoea; and</li>
                    <li>the necessary treatment is total colectomy and ileostomy; and</li>
                    <li>the Diagnosis must be based on histopathological features and confirmed by a Medical
                        Practitioner who is a specialist in gastroenterology.</li>
                </ul>
            </td>
        </tr>
        <tr>
            <td>62.</td>
            <td>Systemic Lupus Erythematosus with Lupus Nephritis</td>
            <td>
                <div>A multi-system autoimmune disorder characterised by the development of autoantibodies directed against various self-antigens. In respect of this Policy, systemic lupus erythematosus will be restricted to those forms of systemic lupus erythematosus which involve the kidneys (Class III to Class V Lupus Nephritis, established by renal biopsy, and in accordance with the WHO Classification). The final Diagnosis must be confirmed by a Medical Practitioner specialising in Rheumatology and Immunology.</div>
                <div>The WHO Classification of Lupus Nephritis:</div>
                <div>Class I Minimal Change Lupus Glomerulonephritis</div>
                <div>Class II Mesangial Lupus Glomerulonephritis</div>
                <div>Class III Focal Segmental Proliferative Lupus Glomerulonephritis</div>
                <div>Class IV Diffuse Proliferative Lupus Glomerulonephritis</div>
                <div>Class V Membranous Lupus Glomerulonephritis</div>
            </td>
        </tr>
        <tr>
            <td>63.</td>
            <td>Terminal Illness</td>
            <td>The conclusive Diagnosis of an illness, which in the opinion of a Medical Practitioner who is an attending Consultant and agreed by our appointed Medical Practitioner, life expectancy is no greater than twelve (12) months from the date of notification of claim, regardless of any treatment that might be undertaken.</td>
        </tr>
        <tr>
            <td>64.</td>
            <td>Tuberculosis Meningitis</td>
            <td>Meningitis caused by tubercle bacilli, resulting in permanent neurological deficit. Such a Diagnosis must be confirmed by a Medical Practitioner who is a specialist in neurology.</td>
        </tr>

        </tbody>
    </table>

</body>